{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.73","value":"53.8"},{"groupId":"OG001","spread":"1.53","value":"66.7"},{"groupId":"OG002","spread":"8.28","value":"46.1"},{"groupId":"OG003","spread":"6.5","value":"64.3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"4"}],"units":"Participants"}],"description":"Metacognition index (MI) was measured by BRIEF test. Assessments within the time window, from eligible and evaluable patients are reported. If the patient had disease progression, only the assessments before progression date were reported. The MI is a standard T- score, and it ranges from 0 to 100. The higher score reported suggests a higher level of dysfunction. Mean and standard deviation of MI were calculated and reported.","dispersionType":"Standard Deviation","groups":[{"description":"SPNET patients who received regimen A (no carboplatin / no isotretinoin)","id":"OG000","title":"Regimen A (SPNET Patients)"},{"description":"SPNET patients who received regimen B (carboplatin / no isotretinoin)","id":"OG001","title":"Regimen B (SPNET Patients)"},{"description":"SPNET patients who received regimen C (no carboplatin / isotretinoin)","id":"OG002","title":"Regimen C (SPNET Patients)"},{"description":"SPNET patients who received regimen D (carboplatin / isotretinoin)","id":"OG003","title":"Regimen D (SPNET Patients)"}],"paramType":"MEAN","populationDescription":"Eligible SPNET patients are included.","reportingStatus":"POSTED","timeFrame":"6 - 12 months post diagnosis","title":"Metacognition Index (MI) on the Behavior Rating Inventory of Executive Function (BRIEF) at 9+/-3 Months Post Diagnosis for SPNET Patients","type":"SECONDARY","unitOfMeasure":"T-Score"}